Equities

Frontage Holdings Corp

Frontage Holdings Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.62
  • Today's Change0.01 / 1.64%
  • Shares traded11.22m
  • 1 Year change-69.46%
  • Beta1.3056
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5591149
Total Receivables, Net797256
Total Inventory2.803.190.95
Prepaid expenses4.625.573.63
Other current assets, total0.410.401.34
Total current assets142172211
Property, plant & equipment, net184180146
Goodwill, net18414971
Intangibles, net373332
Long term investments108.736.91
Note receivable - long term------
Other long term assets7.990.640.53
Total assets572551476
LIABILITIES
Accounts payable131115
Accrued expenses171211
Notes payable/short-term debt0140.01
Current portion long-term debt/capital leases32117.29
Other current liabilities, total385040
Total current liabilities1009773
Total long term debt1139451
Total debt14511858
Deferred income tax121111
Minority interest2.642.773.24
Other liabilities, total2.061218
Total liabilities229218156
SHAREHOLDERS EQUITY
Common stock0.020.020.02
Additional paid-in capital230225227
Retained earnings (accumulated deficit)12111289
Treasury stock - common(4.23)0.00--
Unrealized gain (loss)------
Other equity, total(4.03)(3.94)4.17
Total equity343333320
Total liabilities & shareholders' equity572551476
Total common shares outstanding2,0342,0382,051
Treasury shares - common primary issue29180
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.